Style | Citing Format |
---|---|
MLA | Masoudkabir F, et al.. "Cardiovascular Disease and Cancer: Evidence for Shared Disease Pathways and Pharmacologic Prevention." Atherosclerosis, vol. 263, no. , 2017, pp. 343-351. |
APA | Masoudkabir F, Sarrafzadegan N, Gotay C, Ignaszewski A, Krahn AD, Davis MK, Franco C, Mani A (2017). Cardiovascular Disease and Cancer: Evidence for Shared Disease Pathways and Pharmacologic Prevention. Atherosclerosis, 263(), 343-351. |
Chicago | Masoudkabir F, Sarrafzadegan N, Gotay C, Ignaszewski A, Krahn AD, Davis MK, Franco C, Mani A. "Cardiovascular Disease and Cancer: Evidence for Shared Disease Pathways and Pharmacologic Prevention." Atherosclerosis 263, no. (2017): 343-351. |
Harvard | Masoudkabir F et al. (2017) 'Cardiovascular Disease and Cancer: Evidence for Shared Disease Pathways and Pharmacologic Prevention', Atherosclerosis, 263(), pp. 343-351. |
Vancouver | Masoudkabir F, Sarrafzadegan N, Gotay C, Ignaszewski A, Krahn AD, Davis MK, et al.. Cardiovascular Disease and Cancer: Evidence for Shared Disease Pathways and Pharmacologic Prevention. Atherosclerosis. 2017;263():343-351. |
BibTex | @article{ author = {Masoudkabir F and Sarrafzadegan N and Gotay C and Ignaszewski A and Krahn AD and Davis MK and Franco C and Mani A}, title = {Cardiovascular Disease and Cancer: Evidence for Shared Disease Pathways and Pharmacologic Prevention}, journal = {Atherosclerosis}, volume = {263}, number = {}, pages = {343-351}, year = {2017} } |
RIS | TY - JOUR AU - Masoudkabir F AU - Sarrafzadegan N AU - Gotay C AU - Ignaszewski A AU - Krahn AD AU - Davis MK AU - Franco C AU - Mani A TI - Cardiovascular Disease and Cancer: Evidence for Shared Disease Pathways and Pharmacologic Prevention JO - Atherosclerosis VL - 263 IS - SP - 343 EP - 351 PY - 2017 ER - |